Evidence map›Paper›PMID 30396272›Full record

ArticleACS chemical neuroscience2019

Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.

Songye Li, Zhengxin Cai, Xiaoai Wu, Daniel Holden, Richard Pracitto, Michael Kapinos, Hong Gao, David Labaree, Nabeel Nabulsi, Richard E Carson and 1 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06445582 (Synaptic Vesicle Glycoprotein 2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration), which is not on this map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06445582 unknown statusnot on this mapstarted 2024, after this paper: background citation

Synaptic Vesicle Glycoprotein 2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration

TypeobservationalSponsorAnhui Provincial HospitalRan2024 to 2025Enrolled80ConditionsAlzheimer DiseaseArms[18F]SDM-8
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. First-in-Human Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Trial
  4. Fully Automated Azeotropic Drying-Free Synthesis of [Molecules (Basel, Switzerland) · 2026
    Article
  5. Assessment of noninvasive quantification of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Exploring synaptic density patterns in cerebral small vessel disease: insights from [European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Noninvasive Quantification of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  8. Article
  9. Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison ofAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  10. SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Synthesis, radiolabeling, and evaluation of aFrontiers in bioengineering and biotechnology · 2026
    Article
  13. Article
  14. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  15. Assessing non-invasive quantitative methods for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  16. Article
  17. Presynaptic terminal integrity is associated with glucose metabolism in Parkinson's disease.European journal of nuclear medicine and molecular imaging · 2025
    Article
  18. Article
  19. Triflyl [Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  20. Radiopharmaceuticals and their applications in medicine.Signal transduction and targeted therapy · 2025
    Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Songye LiPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.ORCID 0000-0002-6096-8756
Zhengxin CaiPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Xiaoai WuDepartment of Nuclear Medicine, West China Hospital, Laboratory of Clinical Nuclear Medicine, West China Hospital , Sichuan University , Chengdu 610041 , Sichuan Province , China.
Daniel HoldenPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Richard PracittoPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Michael KapinosPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Hong GaoPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
David LabareePET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Nabeel NabulsiPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Richard E CarsonPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Yiyun HuangPET Center, Department of Radiology and Biomedical Imaging , Yale University School of Medicine , New Haven , Connecticut 06520 , United States.
Yale University · USSichuan University · CN

Funding

PET Imaging of Synaptic Density in Alzheimers DiseaseR01AG052560 · NIA · YALE UNIVERSITY · PI CARSON, RICHARD E., VAN DYCK, CHRISTOPHER H · 2017 to 2020
$3.2M
Development of Novel SV2A PET Agents for Early Detection of Alzheimers DiseaseR01AG058773 · NIA · YALE UNIVERSITY · PI CAI, ZHENGXIN · 2018 to 2020
$2.4M
Synthesis and Evaluation of an 18F Labeled SV2A Ligand as a Novel Biomarker for Alzheimers DiseaseK01EB023312 · NIBIB · YALE UNIVERSITY · PI CAI, ZHENGXIN · 2017 to 2017
$171k
NIA NIH HHS R01 AG052560NIA NIH HHS R01 AG058773NIBIB NIH HHS K01 EB023312
6 · The paper itself

Abstract

Structural disruption and alterations of synapses are associated with many brain disorders including Alzheimer's disease, epilepsy, depression, and schizophrenia. We have previously developed the PET radiotracer

Indexed as

AnimalsDrug Evaluation, PreclinicalGyrus CinguliMacaca mulattaMembrane GlycoproteinsNerve Tissue ProteinsPositron-Emission TomographyPrimatesRadiopharmaceuticalsRatsMembrane GlycoproteinsNerve Tissue ProteinsRadiopharmaceuticalsSV2A protein, human18F-SDM-8nonhuman primatesPETSV2Asynaptic densityUCB-J

Identifiers

PMID30396272
PMCPMC6810685
OpenAlexW2899673110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.